Galderma

Galderma S.A. is a global company specializing in the manufacture and distribution of medical and consumer skin health products, including prescription medicines, medical aesthetic solutions, and skincare items. Founded in 1981 and headquartered in Lausanne, Switzerland, Galderma operates through a network of distributors and has a presence in 80 countries, supported by approximately 6,600 employees. The company’s extensive product portfolio addresses a variety of dermatological conditions such as acne, rosacea, psoriasis, and skin senescence, featuring well-known brands like Epiduo®, Restylane®, and Cetaphil®. With research and development, as well as manufacturing sites in regions including Asia-Pacific, Europe, and the Americas, Galderma is committed to delivering innovative solutions for dermatological needs throughout a person's lifetime.

Jean Falconnet

Vice President of Corporate Development and M&A and Head of Transactions

2 past transactions

Q-Med

Acquisition in 2011
Q-Med is a medical device company focused on the development, manufacturing, marketing, and sale of medical implants. The company is known for its innovative products that utilize its patented technology, NASHA, which allows for the production of stabilized non-animal hyaluronic acid. This technology underpins many of Q-Med's offerings, enabling the company to provide advanced solutions in the medical implant sector.

CollaGenex Pharmaceuticals

Acquisition in 2008
CollaGenex Pharmaceuticals is a medical company based in Newtown, Pennsylvania, that specializes in the development and marketing of innovative proprietary therapies for the dermatology market. The company aims to address various skin-related conditions through its advanced pharmaceutical solutions, contributing to advancements in dermatological care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.